Before the opening bell on Tuesday, a number of big name, dividend paying companies announced their quarterly earnings. Below, we look at these earnings reports and break down the important points for investors.
Pfizer Beats Q1 Estimates
Pfizer (PFE ) reported Q1 earnings of $2.38 billion, or 38 cents per share, up from $2.33 billion, or 36 cents per share, last year. Excluding special items, EPS was 51 cents per share—above analysts’ view of 49 cents.
Revenue dipped 4% to $10.86 billion from $11.35 billion. Analysts expected to see revenue of $10.72 billion.
Looking ahead, PFE expects to see EPS between $1.95 and $2.05. Analysts expect to see EPS of $2.07.
Merck Reports Lower Q1 Results
Merck (MRK ) reported first quarter earnings of $953 million, or 33 cents per share, down from $1.7 billion, or 57 cents per share, last year. Adjusted earnings were 85 cents per share—above analysts’ view of 74 cents per share.
Revenue was $9.42 billion from $10.26 billion last year. Analysts expected to see $8.99 billion in revenue.
Bristol-Myers Beats Q1 Estimates
Bristol-Myers Squibb (BMY ) reported Q1 earnings of $1.2 billion, or 71 cents per share, up from $937 million, or 56 cents per share, last year. Adjusted EPS came in at $1.2 billion, or 71 cents—well above analysts’ estimate of 50 cents.
Revenue increased 6% to $4.0 billion. Analysts expected to see revenue of $3.80 billion.
UPS Posts Higher Q1 Results
United Parcel Service (UPS ) reported first quarter earnings of $1.026 billion, or $1.12 per share, up from $911 million, or 98 cents per share, a year ago. On average, analysts expected to see EPS of $1.09.
Revenue grew 14% to $14.0 billion. Analysts expected to see revenue of $14.27 billion.